HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. Aug 2011 - :1432-1440 [PMID:21845448] [Zizzari IG] [Veglia F] [Taurino F] [Rahimi H] [Quaglino E] [Belleudi F] [Riccardo F] [Antonilli M] [Napoletano C] [Bellati F] [Benedetti-Panici P] [Torrisi MR] [Frati L] [Nuti M] [Rughetti A]
